Findings

What do systematic reviews say?

4,783 questions · 10,022 findings · 882 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2,100 · 21%GRADE not reported 1,013 · 10.1%Very low 2,237 · 22.3%Low 2,514 · 25.1%Moderate 1,709 · 17.1%High 449 · 4.5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Cough augmentation therapy vs usual care

Peak cough flow for 'rescue' or 'maintenance' therapy · participants with chronic neuromuscular diseases

The review found no eligible studies for this question.

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cough augmentation therapy vs usual care

Any adverse events for 'rescue' and 'maintenance' therapy · participants with chronic neuromuscular diseases

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 67 participants
Very low

Cough augmentation therapy vs usual care

Participant preference or satisfaction for 'rescue' and 'maintenance' therapy · participants with chronic neuromuscular diseases

The review found no eligible studies for this question.

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cough augmentation therapy vs an alternative cough augmentation technique or combination of techniques

Duration of hospital stay (days) for 'rescue' therapy · participants with chronic neuromuscular diseases

The review found no eligible studies for this question.

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cough augmentation therapy vs an alternative cough augmentation technique or combination of techniques

Quality of life for 'maintenance' therapy · participants with chronic neuromuscular diseases

The review found no eligible studies for this question.

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cough augmentation therapy vs an alternative cough augmentation technique or combination of techniques

Participant preference or satisfaction for 'rescue' and 'maintenance' therapy · participants with chronic neuromuscular diseases

The review found no eligible studies for this question.

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cough augmentation therapy vs usual care

Number of unscheduled hospital admissions for 'maintenance therapy' · participants with chronic neuromuscular diseases

The review found no eligible studies for this question.

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cough augmentation therapy vs usual care

Duration of hospital stay (days) for 'rescue' therapy · participants with chronic neuromuscular diseases

The review found no eligible studies for this question.

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cough augmentation therapy vs usual care

Quality of life for 'maintenance' therapy · participants with chronic neuromuscular diseases

The review found no eligible studies for this question.

1 finding from 1 review

Cough augmentation techniques for people with chronic neuromuscular disorders 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Foam sclerotherapy vs foam sclerotherapy

QoL · participants with varicose veinsa

The review found no eligible studies for this question.

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Foam sclerotherapy vs foam sclerotherapy

Persistence of symptoms · participants with varicose veinsa

The review found no eligible studies for this question.

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Foam sclerotherapy vs foam sclerotherapy

Recurrent varicose veins · participants with varicose veinsa

Foam sclerotherapy showed no clear difference in recurrent varicose veins compared with foam sclerotherapy (low certainty).

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
RR 0.91 [0.62, 1.32]
1 study · 148 participants
Low

Foam sclerotherapy vs liquid sclerotherapy

Cosmetic appearance · participants with varicose veinsa

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 126 participants
Very low

Foam sclerotherapy vs liquid sclerotherapy

Complications ‐ DVT · participants with varicose veinsa

The review found no eligible studies for this question.

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Foam sclerotherapy vs liquid sclerotherapy

Residual varicose veins · participants with varicose veinsa

It is very uncertain whether foam sclerotherapy changes residual varicose veins compared with liquid sclerotherapy (very low certainty).

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
RR 0.51 [0.41, 0.65]
2 studies · 203 participants
Very low

Foam sclerotherapy vs liquid sclerotherapy

QoL · participants with varicose veinsa

The review found no eligible studies for this question.

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Foam sclerotherapy vs liquid sclerotherapy

Persistence of symptoms · participants with varicose veinsa

The review found no eligible studies for this question.

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Foam sclerotherapy vs liquid sclerotherapy

Recurrent varicose veins · participants with varicose veinsa

It is very uncertain whether foam sclerotherapy changes recurrent varicose veins compared with liquid sclerotherapy (very low certainty).

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
RR 1.1 [0.86, 1.42]
1 study · 286 participants
Very low

Foam sclerotherapy vs foam sclerotherapy

Cosmetic appearance · participants with varicose veinsa

It is very uncertain whether foam sclerotherapy changes cosmetic appearance (self‐described cosmetic improvement) compared with foam sclerotherapy (very low certainty).

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
RR 1.11 [0.84, 1.47]
1 study · 80 participants
Very low

Foam sclerotherapy vs foam sclerotherapy

Number of thromboembolic complications · participants with varicose veinsa

It is very uncertain whether foam sclerotherapy changes complications ‐ thromboembolic compared with foam sclerotherapy (very low certainty).

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
RR 1.47 [0.41, 5.33]
3 studies · 371 participants
Very low